206 related articles for article (PubMed ID: 35147200)
1. Expression of
Icduygu FM; Akgun E; Sengul D; Ozgoz A; Alp E
Mol Med Rep; 2022 Apr; 25(4):. PubMed ID: 35147200
[TBL] [Abstract][Full Text] [Related]
2. Down-regulation of DANCR acts as a potential biomarker for papillary thyroid cancer diagnosis.
Zhang K; Lv J; Peng X; Liu J; Li C; Li J; Yin N; Li H; Li Z
Biosci Rep; 2019 Apr; 39(4):. PubMed ID: 30910839
[TBL] [Abstract][Full Text] [Related]
3. lncRNA DUXAP8 inhibits papillary thyroid carcinoma cell apoptosis via sponging the miR‑20b‑5p/SOS1 axis.
Pang R; Yang S
Oncol Rep; 2021 May; 45(5):. PubMed ID: 33760128
[TBL] [Abstract][Full Text] [Related]
4. Expression profile of long noncoding RNAs in human papillary thyroid carcinoma.
Cao Y; Shi C; Li J; Liang Y; Qiu J; Yuan L; Yong Z; Zhang DX; Shi GQ
Neoplasma; 2019 Mar; 66(2):245-251. PubMed ID: 30569720
[TBL] [Abstract][Full Text] [Related]
5. Upregulation and the clinical significance of KCNQ1OT1 and HAGLROS lncRNAs in papillary thyroid cancer: An observational study.
Mutlu Icduygu F; Akgun E; Ozgoz A; Hekimler Ozturk K; Sengul D; Alp E
Medicine (Baltimore); 2023 Jul; 102(29):e34379. PubMed ID: 37478216
[TBL] [Abstract][Full Text] [Related]
6. Long noncoding RNA RP11-547D24.1 regulates proliferation and migration in papillary thyroid carcinoma: Identification and validation of a novel long noncoding RNA through integrated analysis of TCGA database.
Guo K; Chen L; Wang Y; Qian K; Zheng X; Sun W; Sun T; Wu Y; Wang Z
Cancer Med; 2019 Jun; 8(6):3105-3119. PubMed ID: 31044550
[TBL] [Abstract][Full Text] [Related]
7. Long noncoding RNA HIT000218960 promotes papillary thyroid cancer oncogenesis and tumor progression by upregulating the expression of high mobility group AT-hook 2 (HMGA2) gene.
Li T; Yang XD; Ye CX; Shen ZL; Yang Y; Wang B; Guo P; Gao ZD; Ye YJ; Jiang KW; Wang S
Cell Cycle; 2017 Jan; 16(2):224-231. PubMed ID: 27929737
[TBL] [Abstract][Full Text] [Related]
8. A novel lncRNA n384546 promotes thyroid papillary cancer progression and metastasis by acting as a competing endogenous RNA of miR-145-5p to regulate AKT3.
Feng J; Zhou Q; Yi H; Ma S; Li D; Xu Y; Wang J; Yin S
Cell Death Dis; 2019 Jun; 10(6):433. PubMed ID: 31160577
[TBL] [Abstract][Full Text] [Related]
9. Downregulation of long noncoding RNA NONHSAT037832 in papillary thyroid carcinoma and its clinical significance.
Lan X; Sun W; Zhang P; He L; Dong W; Wang Z; Liu S; Zhang H
Tumour Biol; 2016 May; 37(5):6117-23. PubMed ID: 26611646
[TBL] [Abstract][Full Text] [Related]
10. Long non-coding RNA TTN-AS1 facilitates tumorigenesis of papillary thyroid cancer through modulating the miR-153-3p/ZNRF2 axis.
Cui Z; Luo Z; Lin Z; Shi L; Hong Y; Yan C
J Gene Med; 2019 May; 21(5):e3083. PubMed ID: 30811764
[TBL] [Abstract][Full Text] [Related]
11. Integrated analysis of long noncoding RNA interactions reveals the potential role in progression of human papillary thyroid cancer.
You X; Zhao Y; Sui J; Shi X; Sun Y; Xu J; Liang G; Xu Q; Yao Y
Cancer Med; 2018 Nov; 7(11):5394-5410. PubMed ID: 30318850
[TBL] [Abstract][Full Text] [Related]
12. Identification of Specific Long Non-Coding RNA Expression: Profile and Analysis of Association with Clinicopathologic Characteristics and BRAF Mutation in Papillary Thyroid Cancer.
Wang Q; Yang H; Wu L; Yao J; Meng X; Jiang H; Xiao C; Wu F
Thyroid; 2016 Dec; 26(12):1719-1732. PubMed ID: 27758138
[TBL] [Abstract][Full Text] [Related]
13. High expression of LINC0163 promotes progression of papillary thyroid cancer by regulating epithelial-mesenchymal transition MITF.
Gao P; Jiao H; Zhe L; Cui J
Eur Rev Med Pharmacol Sci; 2020 May; 24(10):5504-5511. PubMed ID: 32495885
[TBL] [Abstract][Full Text] [Related]
14. Silencing long non-coding RNAs nicotinamide nucleotide transhydrogenase antisense RNA 1 inhibited papillary thyroid cancer cell proliferation, migration and invasion and promoted apoptosis via targeting miR-199a-5p.
Wang D; Zheng Y
Endocr J; 2021 May; 68(5):583-597. PubMed ID: 33612561
[TBL] [Abstract][Full Text] [Related]
15. Overexpression of novel long intergenic non‑coding RNA LINC02454 is associated with a poor prognosis in papillary thyroid cancer.
Tan J; Liu L; Zuo Z; Song B; Cai T; Ding D; Lu Y; Ye X
Oncol Rep; 2020 Oct; 44(4):1489-1501. PubMed ID: 32945494
[TBL] [Abstract][Full Text] [Related]
16. Relationship of Focally Amplified Long Noncoding on Chromosome 1 (FAL1) lncRNA with E2F Transcription Factors in Thyroid Cancer.
Jeong S; Lee J; Kim D; Seol MY; Lee WK; Jeong JJ; Nam KH; Jung SG; Shin DY; Lee EJ; Chung WY; Jo YS
Medicine (Baltimore); 2016 Jan; 95(4):e2592. PubMed ID: 26825907
[TBL] [Abstract][Full Text] [Related]
17. Long Non-Coding RNAs Profiling Using Microarray in Papillary Thyroid Carcinoma.
Islam F; Zhou Y; Lam AK
Methods Mol Biol; 2022; 2534():135-148. PubMed ID: 35670973
[TBL] [Abstract][Full Text] [Related]
18. LncRNA CASC15 promotes the proliferation of papillary thyroid carcinoma cells by regulating the miR-7151-5p/WNT7A axis.
Bai D; Guo C; Wang A; Pang G; Gao J; Wang C; Zhao D; Yang J; Ren J
Pathol Res Pract; 2021 Sep; 225():153561. PubMed ID: 34325316
[TBL] [Abstract][Full Text] [Related]
19. Integrated analysis identifying new lncRNA markers revealed in ceRNA network for tumor recurrence in papillary thyroid carcinoma and build of nomogram.
Chen F; Li Z; Deng C; Yan H
J Cell Biochem; 2019 Dec; 120(12):19673-19683. PubMed ID: 31271223
[TBL] [Abstract][Full Text] [Related]
20. Genome-wide analysis of long noncoding RNA expression profile in papillary thyroid carcinoma.
Lan X; Zhang H; Wang Z; Dong W; Sun W; Shao L; Zhang T; Zhang D
Gene; 2015 Sep; 569(1):109-17. PubMed ID: 26003293
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
